Published in Hypertension on April 01, 2001
Pulsatile versus oscillatory shear stress regulates NADPH oxidase subunit expression: implication for native LDL oxidation. Circ Res (2003) 2.13
2009 Canadian Hypertension Education Program recommendations: an annual update. Can Fam Physician (2009) 2.03
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia (2008) 1.70
Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev (2012) 1.61
Diabetes downregulates large-conductance Ca2+-activated potassium beta 1 channel subunit in retinal arteriolar smooth muscle. Circ Res (2007) 1.52
The rising burden of diabetes and hypertension in southeast asian and african regions: need for effective strategies for prevention and control in primary health care settings. Int J Hypertens (2013) 1.50
BP, cardiovascular disease, and death in the Folic Acid for Vascular Outcome Reduction in Transplantation trial. J Am Soc Nephrol (2014) 1.42
Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients. J Pharmacol Pharmacother (2016) 1.39
Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration. Free Radic Biol Med (2006) 1.25
Mechanisms of cardiac dysfunction in obstructive sleep apnea. Nat Rev Cardiol (2012) 1.22
In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease. Vasc Health Risk Manag (2005) 1.22
Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and stroke. Neuromolecular Med (2011) 1.20
A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol (2007) 1.20
Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy. J Cell Mol Med (2009) 1.19
Hypertension in people with type 2 diabetes: Update on pharmacologic management. Can Fam Physician (2011) 1.17
Identifying patients with chronic conditions using pharmacy data in Switzerland: an updated mapping approach to the classification of medications. BMC Public Health (2013) 1.17
Cardiometabolic risk factors assessed by a finger stick dried blood spot method. J Diabetes Sci Technol (2008) 1.16
The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci (2009) 1.14
Hypertension in diabetes: a call to action. Can J Cardiol (2009) 1.10
Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol (2005) 1.06
Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats. Cardiovasc Diabetol (2010) 1.06
Potential national and state medical care savings from primary disease prevention. Am J Public Health (2010) 1.05
Shear stress influences spatial variations in vascular Mn-SOD expression: implication for LDL nitration. Am J Physiol Cell Physiol (2008) 1.04
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc (2004) 1.04
2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update. Can J Cardiol (2009) 1.03
Sociodemographic risk factors of diabetes and hypertension prevalence in republic of Korea. Int J Hypertens (2010) 1.01
Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Serv Res (2008) 1.01
Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond) (2009) 1.01
Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochim Biophys Acta (2010) 0.99
Eicosanoids and renal damage in cardiometabolic syndrome. Expert Opin Drug Metab Toxicol (2008) 0.99
Probiotics and their Effects on Metabolic Diseases: An Update. J Clin Diagn Res (2013) 0.97
Blood pressure and lipid management fall far short in persons with type 2 diabetes: results from the DIAB-CORE Consortium including six German population-based studies. Cardiovasc Diabetol (2012) 0.96
Acute Coronary Syndrome, Diabetes and Hypertension: Oman must pay more attention to chronic non-communicable diseases. Sultan Qaboos Univ Med J (2011) 0.96
Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study. PLoS One (2012) 0.95
Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J (2009) 0.95
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes. Cardiovasc Res (2009) 0.95
Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am (2013) 0.95
Diabetic cardiomyopathy and its mechanisms: Role of oxidative stress and damage. J Diabetes Investig (2014) 0.94
What women want: understanding obesity and preferences for primary care weight reduction interventions among African-American and Caucasian women. J Natl Med Assoc (2006) 0.93
Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo. Cardiovasc Diabetol (2013) 0.92
Cardiac-specific overexpression of CYP2J2 attenuates diabetic cardiomyopathy in male streptozotocin-induced diabetic mice. Endocrinology (2013) 0.90
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag (2009) 0.90
Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension. Can Fam Physician (2013) 0.90
[Heart failure in diabetes]. Wien Med Wochenschr (2009) 0.90
Rescue of Heart Failure by Mitochondrial Recovery. Int Neurourol J (2016) 0.89
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy. Diabetes (2013) 0.89
Trends in hypertension prevalence, awareness, treatment and control in an adult type 2 diabetes Spanish population between 2003 and 2009. PLoS One (2014) 0.89
Hypertension and type 2 diabetes: a cross-sectional study in Morocco (EPIDIAM Study). Pan Afr Med J (2012) 0.88
Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation. Cardiovasc Diabetol (2014) 0.88
Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev (2014) 0.88
Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol (2004) 0.88
The role of dermcidin isoform 2: a two-faceted atherosclerotic risk factor for coronary artery disease and the effect of acetyl salicylic Acid on it. Thrombosis (2012) 0.87
Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence (2011) 0.87
Blood pressure lowering in patients with diabetes--one level might not fit all. Nat Rev Cardiol (2010) 0.86
Cardiovascular risk factor distribution and subjective risk estimation in urban women--the BEFRI study: a randomized cross-sectional study. BMC Med (2015) 0.85
Dapagliflozin added to glimepiride in patients with type 2 diabetes mellitus sustains glycemic control and weight loss over 48 weeks: a randomized, double-blind, parallel-group, placebo-controlled trial. Diabetes Ther (2014) 0.85
Distorted self-perceived weight status and underestimation of weight status in diabetes mellitus type 2 patients. PLoS One (2014) 0.84
Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes (2013) 0.84
Association between dentures and the rate of falls in dementia. Med Devices (Auckl) (2014) 0.84
Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome. Nutr Metab (Lond) (2010) 0.83
Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol (2013) 0.83
Hypertension among rural population in four states: Sudan 2012. Glob J Health Sci (2014) 0.83
Cardiovascular dementia - a different perspective. Open Biochem J (2010) 0.83
Mechanisms underlying the impaired contractility of diabetic cardiomyopathy. World J Cardiol (2014) 0.83
Genetic predisposition to high blood pressure associates with cardiovascular complications among patients with type 2 diabetes: two independent studies. Diabetes (2012) 0.83
Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia (2008) 0.82
Testing the effectiveness of a mindfulness-based intervention to reduce emotional distress in outpatients with diabetes (DiaMind): design of a randomized controlled trial. BMC Public Health (2011) 0.82
Diabetic nephropathy: Treatment with phosphodiesterase type 5 inhibitors. World J Diabetes (2013) 0.82
Impaired insulin-stimulated myosin phosphatase Rho-interacting protein signaling in diabetic Goto-Kakizaki vascular smooth muscle cells. Am J Physiol Cell Physiol (2012) 0.82
Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile dysfunction and aggravates I/R injury in STZ-diabetic rats. J Biomed Sci (2009) 0.82
The influence of diabetes on cardiac beta-adrenoceptor subtypes. Heart Fail Rev (2007) 0.82
Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism. Mol Nutr Food Res (2012) 0.81
Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats. Adv Pharm Bull (2015) 0.81
An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice. PLoS One (2013) 0.81
Acquired immunodeficiency syndrome in older African Americans. J Natl Med Assoc (2002) 0.81
Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats. Cardiovasc Diabetol (2013) 0.81
Visceral adipose tissue: emerging role of gluco- and mineralocorticoid hormones in the setting of cardiometabolic alterations. Ann N Y Acad Sci (2012) 0.80
Undiagnosed hypertension in a rural district in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES). J Hum Hypertens (2015) 0.80
Should we treat prehypertension in diabetes? What are the cons? Diabetes Care (2009) 0.80
The effects of type 1 diabetes on the hypothalamic, pituitary and testes axis. Cell Tissue Res (2012) 0.80
Elevated serum levels of interleukin-18 in patients with overt diabetic nephropathy: effects of miglitol. Clin Exp Nephrol (2010) 0.80
Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa. PLoS One (2016) 0.80
Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radic Biol Med (2015) 0.80
Assessment of the common risk factors associated with type 2 diabetes mellitus in jeddah. Int J Endocrinol (2014) 0.79
Is prehypertension a risk factors for cardiovascular diseases among Iranian women? J Res Med Sci (2012) 0.79
Perceived discrimination and markers of cardiovascular risk among low-income African American youth. Am J Hum Biol (2015) 0.79
The 14 bp Del/Ins HLA-G polymorphism is related with high blood pressure in acute coronary syndrome and type 2 diabetes mellitus. Biomed Res Int (2014) 0.79
Arterial hypertension - prevalence of risk factors and morbide associations that increase cardiovascular risk. Maedica (Buchar) (2010) 0.79
G-protein-coupled receptor kinase 2 and endothelial dysfunction: molecular insights and pathophysiological mechanisms. J Smooth Muscle Res (2015) 0.79
Evidence-based hypertension treatment in patients with diabetes. J Clin Hypertens (Greenwich) (2011) 0.78
Longitudinal prevalence of hypertension, proteinuria, and retinopathy in dogs with spontaneous diabetes mellitus. J Vet Intern Med (2014) 0.78
Can Aliskiren be Considered as a New Novel Drug for Hypertension? Cureus (2015) 0.78
Dietary inorganic nitrate: From villain to hero in metabolic disease? Mol Nutr Food Res (2015) 0.78
Regulation of type IV collagen alpha chains of glomerular epithelial cells in diabetic conditions. J Korean Med Sci (2009) 0.78
Resistin Induces Hypertension and Insulin Resistance in Mice via a TLR4-Dependent Pathway. Sci Rep (2016) 0.78
Awaking Blood Pressure Surge and Progression to Microalbuminuria in Type 2 Normotensive Diabetic Patients. J Diabetes Res (2015) 0.77
Hydrogen Sulfide Prevents Advanced Glycation End-Products Induced Activation of the Epithelial Sodium Channel. Oxid Med Cell Longev (2015) 0.77
A novel mouse model of advanced diabetic kidney disease. PLoS One (2014) 0.77
Incretins in type 2 diabetes mellitus: cardiovascular and anti-atherogenic effects beyond glucose lowering. Hippokratia (2012) 0.77
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (1988) 4.32
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis (2000) 3.37
Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med (1970) 2.43
Reduction of high-risk sexual behavior among heterosexuals undergoing HIV antibody testing: a randomized clinical trial. Am J Public Health (1991) 2.22
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension (2001) 2.20
Perioperative torsade de pointes ventricular tachycardia induced by hypocalcemia and hypokalemia. Anesth Analg (1995) 2.11
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Morbidity and treatment in general practice in Australia 1990-1991. Med J Aust (1993) 1.99
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasis. Physiol Rev (1978) 1.98
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation (1968) 1.82
Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res (1981) 1.75
One-year longitudinal study of a no-smoking policy in a medical institution. Chest (1990) 1.75
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol (1989) 1.68
Long-term analysis of cerebrospinal fluid shunt infections. A 25-year experience. J Neurosurg (1979) 1.64
Evaluation of the initial care of hypertensive patients. JAMA (1971) 1.64
Reconstitution of carbamylcholine-dependent sodium ion flux and desensitization of the acetylcholine receptor from Torpedo californica. J Biol Chem (1978) 1.59
Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion (1989) 1.57
Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med (1966) 1.57
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension (1995) 1.50
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med (1999) 1.50
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up. Cardiovasc Res (2000) 1.49
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech Dev (1997) 1.47
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.46
Evaluation of the finite element software ABAQUS for biomechanical modelling of biphasic tissues. J Biomech (1998) 1.43
The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol (1989) 1.39
Hypertension means high blood pressure. Hypertension (1994) 1.39
Under-reporting of psychiatric illness. Aust Fam Physician (1993) 1.38
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med (1998) 1.28
Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore) (1968) 1.28
Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med (1976) 1.27
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Pneumococcal peritonitis in patients with postnecrotic cirrhosis. N Engl J Med (1968) 1.25
Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab (1996) 1.24
Effects of aging on the kidney. Fed Proc (1979) 1.24
Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens (1997) 1.24
Joint contact mechanics in the early stages of osteoarthritis. Med Eng Phys (2000) 1.20
Simultaneous ocular and orbital involvement from metastatic bronchogenic carcinoma. Ann Ophthalmol (1982) 1.19
Effects of water immersion to the neck on pulmonary circulation and tissue volume in man. J Appl Physiol (1976) 1.18
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
Binding of lanthanides and of divalent metal ions to porcine trypsin. Biochemistry (1974) 1.17
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Effects of dietary cholesterol and fatty acids on plasma lipoproteins. J Clin Invest (1982) 1.17
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol (1979) 1.14
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Effect of sodium balance on intrarenal distribution of blood flow in normal man. J Appl Physiol (1970) 1.13
Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod (1999) 1.13
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
Presence of a natriuretic factor in urine of normal men undergoing water immersion. Kidney Int (1978) 1.12
An overtube for the flexible fiberoptic esophagogastroduodenoscope. Gastrointest Endosc (1982) 1.11
Left ventricular hypertrophy and sudden death. J Am Coll Cardiol (1998) 1.11
Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am J Physiol (1978) 1.10
Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. J Biol Chem (1981) 1.09
Relationship between renal prostaglandin E and renal sodium handling during water immersion in normal man. Circ Res (1979) 1.08
Isolated right pulmonary artery discontinuity. Images Paediatr Cardiol (2000) 1.08
A renewed call to mentor. Hypertension (2000) 1.08
Treatment of refractory ascites. N Engl J Med (1989) 1.08
Editorial: Use and abuse of diuretics. Am Heart J (1975) 1.07
Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res (1976) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
New chart to evaluate weight faltering. Arch Dis Child (1998) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
Impaired myogenic responsiveness of renal microvessels in Dahl salt-sensitive rats. Circ Res (1992) 1.06
Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention. Ann Intern Med (1983) 1.04
Comparison of speech production in upright and supine position. J Acoust Soc Am (2007) 1.04
Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol (1990) 1.03
Suppression of ADH during water immersion in normal man. J Appl Physiol (1975) 1.03
The effect of cortisone on femoral and humeral heads in rabbits. An experimental study. Clin Orthop Relat Res (1972) 1.03
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am J Physiol (1989) 1.02
A new method of preparing Ca2+-ATPase from sarcoplasmic reticulum: extraction with octylglucoside. Membr Biochem (1979) 1.01
Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations. Hum Reprod (2001) 1.01
Modelling of location- and time-dependent deformation of chondrocytes during cartilage loading. J Biomech (1999) 1.01
Characterization of the natriuresis caused in normal man by immersion in water. Clin Sci (1972) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (2001) 1.00
Recent advances on large arteries in hypertension. Hypertension (1998) 1.00
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension (1996) 0.99
Effect of intrarenal furosemide on renal function and intratenal hemodynamics in acute renal failure. Am J Med (1975) 0.99
Physiological comparison of labile and essential hypertension. Circ Res (1970) 0.99
Relationship between plasma arginine vasopressin and renal water handling in decompensated cirrhosis. Miner Electrolyte Metab (1984) 0.99
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Beta adrenergic blockade in the circulatory regulation of hyperkinetic states. Am J Cardiol (1971) 0.98
Effects of calcium antagonists on renal hemodynamics. Am J Physiol (1985) 0.98
Recommendations for blood pressure determination by sphygmomanometry. Ann Intern Med (1988) 0.98
Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J Am Soc Nephrol (1992) 0.98